Business context and reporting period
The supplied filing is Central Valley Community Bancorp’s unaudited Form 10-Q for the quarter ended March 31, 2020, not a filing identified as Community West Bancshares. Central Valley Community Bancorp (ticker CVCY) is a California bank holding company operating Central Valley Community Bank, serving businesses and individuals in central California. Verify the intended issuer before relying on this summary.
Financial performance and condition
| Metric | Q1 2020 | Comparable period / prior date |
|---|---|---|
| Net interest income before credit-loss provision | $16.0 million | $15.8 million in Q1 2019 |
| Provision for credit losses | $1.4 million | $25,000 reversal in Q1 2019 |
| Net income | $6.6 million | $5.2 million in Q1 2019 |
| Diluted earnings per share | $0.52 | $0.38 in Q1 2019 |
| Net interest margin, fully tax-equivalent | 4.47% | 4.63% in Q1 2019 |
| Total assets | $1.619 billion | $1.597 billion at Dec. 31, 2019 |
| Gross loans | $929.8 million | $943.4 million at Dec. 31, 2019 |
| Total deposits | $1.351 billion | $1.333 billion at Dec. 31, 2019 |
| Shareholders’ equity | $218.7 million | $228.1 million at Dec. 31, 2019 |
- Net income rose 27% year over year, largely reflecting higher realized gains on investment securities. Non-interest income increased to $6.5 million from $3.0 million; securities gains were $4.2 million, compared with $1.1 million in Q1 2019. Other income included a $297,000 gain related to life insurance proceeds.
- Non-interest expense increased 3.5% to $12.1 million. Salary and benefits rose by $1.0 million, including an approximately $646,000 impact from changes in discount rates for benefit-plan liabilities.
- Operating cash flow was $5.9 million, versus $6.9 million in Q1 2019. Cash and cash equivalents declined to $36.2 million from $52.6 million at year-end. Investing activities used $27.5 million, while financing activities provided $5.1 million.
- The allowance for credit losses rose to $10.5 million, or 1.13% of gross loans, from $9.1 million, or 0.97%, at year-end. Nonperforming loans were $1.1 million (0.12% of loans), down from $1.7 million (0.18%) at year-end. Impaired loans increased to $16.1 million from $3.7 million.
- At March 31, the company had $5.2 million of junior subordinated debentures and no FHLB advances or federal funds purchased. The Bank reported capital ratios above “well-capitalized” thresholds: 10.86% Tier 1 leverage and 15.23% total risk-based capital.
- Available liquidity included $36.2 million cash and cash equivalents, $440.6 million of unpledged securities, $70 million of unsecured correspondent lines, $257.1 million of unused FHLB capacity, and a $15.5 million Federal Reserve credit line. The loan-to-deposit ratio was 68.84%.
Material changes and unusual items
- Net interest margin declined 16 basis points year over year to 4.47%, as lower asset yields and a slightly higher cost of interest-bearing liabilities offset growth in average earning assets.
- The first-quarter credit-loss provision reflected management’s adjustment of economic risk factors for COVID-19 and rising unemployment. Net charge-offs were limited; the quarter recorded net recoveries of approximately $41,000.
- The available-for-sale securities portfolio moved from a $4.0 million net unrealized gain at year-end to a $1.9 million net unrealized loss at March 31. The company recorded no other-than-temporary impairment losses in the quarter and attributed unrealized losses primarily to interest-rate changes.
- Shareholders’ equity fell partly because of $11.1 million in share repurchases, $1.4 million in dividends, and a $4.1 million after-tax decline in accumulated other comprehensive income. The board declared a further $0.11-per-share dividend on April 15, payable May 15.
- Recorded troubled-debt-restructuring investments were $15.1 million at March 31, versus $2.4 million at year-end; two loans were modified as TDRs during the quarter. The filing states that short-term COVID-related payment deferrals under applicable guidance were not classified as TDRs.
Outlook, COVID-19, and risks
- Management said the pandemic’s ultimate financial impact was not estimable. It cited risks to borrowers’ ability to repay, future credit provisions, interest income, collateral values, asset valuations, liquidity, and net interest margin. Management also warned that a prolonged downturn could prompt goodwill or intangible-asset impairment testing.
- As of March 31, the Bank had granted payment deferrals on loans totaling approximately $115 million. By April 30, it reported 229 executed deferrals on $137 million of balances and 69 additional requests covering $46 million in process.
- As of April 30, the company reported 1,016 PPP loans closed or SBA-approved, representing $210 million in funding. Estimated SBA fees would be approximately $6.9 million if the applications in process were approved and funded. These are subsequent-period developments, not Q1 results.
- Management said it was monitoring borrower and portfolio risks, stress-testing loans and investments, and shifting resources to credit administration. It expected to remain adequately capitalized, while acknowledging uncertainty and the possibility of increased losses if economic conditions worsened.
- Other stated risks include concentration in commercial and real-estate lending, exposure to central California agriculture and real estate, interest-rate sensitivity, deposit outflows or higher funding costs, and reliance on key employees and third-party providers. No legal proceedings were reported as material, and management reported effective disclosure controls.
- The company was evaluating CECL implementation and expected to adopt on January 1, 2023, under the extended effective date for qualifying smaller reporting companies; the adoption impact was not yet reasonably estimable.
Important facts for investors to verify
- Confirm issuer identity: the provided filing is for Central Valley Community Bancorp (CVCY), not Community West Bancshares.
- Assess how much of the earnings increase came from securities-sale gains and other nonrecurring income, and whether these gains are repeatable.
- Track COVID-related deferrals, PPP loan funding and fee recognition, borrower performance after deferral periods, TDRs, impaired loans, and future allowance provisions.
- Monitor margin trends, deposit mix and funding costs, liquidity availability, capital ratios, and the effect of further market-value changes in the securities portfolio.
- Review the effects of completed stock repurchases and dividends on capital and per-share results; determine whether subsequent periods sustain earnings without comparable repurchase or securities gains.